158 related articles for article (PubMed ID: 35051421)
21. 5-HT modulates the rat mesenteric vasopressor outflow by 5-HT
García-Pedraza JÁ; García-Domingo M; Gómez-Roso M; Rodríguez-Barbero A; Martín ML; Morán A
Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1224-1231. PubMed ID: 28771848
[TBL] [Abstract][Full Text] [Related]
22. Peripheral and spinal 5-HT receptors participate in the pronociceptive and antinociceptive effects of fluoxetine in rats.
Cervantes-Durán C; Rocha-González HI; Granados-Soto V
Neuroscience; 2013 Nov; 252():396-409. PubMed ID: 23994595
[TBL] [Abstract][Full Text] [Related]
23. Effects of fluoxetine and buspirone on the panicolytic-like response induced by the activation of 5-HT1A and 5-HT2A receptors in the rat dorsal periaqueductal gray.
de Bortoli VC; Nogueira RL; Zangrossi H
Psychopharmacology (Berl); 2006 Jan; 183(4):422-8. PubMed ID: 16258751
[TBL] [Abstract][Full Text] [Related]
24. Diabetes attenuates the antidepressant-like effect mediated by the activation of 5-HT1A receptor in the mouse tail suspension test.
Miyata S; Hirano S; Kamei J
Neuropsychopharmacology; 2004 Mar; 29(3):461-9. PubMed ID: 14628002
[TBL] [Abstract][Full Text] [Related]
25. Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex.
Invernizzi R; Bramante M; Samanin R
Pharmacol Biochem Behav; 1996 May; 54(1):143-7. PubMed ID: 8728551
[TBL] [Abstract][Full Text] [Related]
26. Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors.
Gobert A; Millan MJ
Neuropsychopharmacology; 1999 Aug; 21(2):268-84. PubMed ID: 10432475
[TBL] [Abstract][Full Text] [Related]
27. Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex.
Dawson LA; Nguyen HQ; Smith DL; Schechter LE
J Psychopharmacol; 2002 Jun; 16(2):145-52. PubMed ID: 12095073
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological evidence that 5-HT1A/1B/1D, α2-adrenoceptors and D2-like receptors mediate ergotamine-induced inhibition of the vasopressor sympathetic outflow in pithed rats.
Villamil-Hernández MT; Alcántara-Vázquez O; Sánchez-López A; Gutiérrez-Lara EJ; Centurión D
Eur J Pharmacol; 2014 Oct; 740():512-21. PubMed ID: 24975101
[TBL] [Abstract][Full Text] [Related]
29. Chronic fluoxetine treatment selectively uncouples raphe 5-HT(1A) receptors as measured by [(35)S]-GTP gamma S autoradiography.
Pejchal T; Foley MA; Kosofsky BE; Waeber C
Br J Pharmacol; 2002 Mar; 135(5):1115-22. PubMed ID: 11877317
[TBL] [Abstract][Full Text] [Related]
30. Fluoxetine attenuates thermal hyperalgesia through 5-HT1/2 receptors in streptozotocin-induced diabetic mice.
Anjaneyulu M; Chopra K
Eur J Pharmacol; 2004 Aug; 497(3):285-92. PubMed ID: 15336946
[TBL] [Abstract][Full Text] [Related]
31. Participation of cyclooxygenase pathway in the vasoconstriction induced by 5-HT in the in situ autoperfused kidney of long-term diabetic rats.
Restrepo B; García M; Rodríguez-Barbero A; Román LS; Martin ML; Morán A
Eur J Pharmacol; 2011 May; 659(1):37-44. PubMed ID: 21414306
[TBL] [Abstract][Full Text] [Related]
32. Chronic treatment with fluoxetine decreases cerebral metabolic responses to the 5-HT1A agonist 8-hydroxy-2(di-N-propylamino)tetralin and increases those to the 5-HT2A/2C agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane and to the dopaminergic agonist apomorphine.
Freo U; Merico A; Ermani M; Ori C
Brain Res; 2010 Jun; 1335():24-34. PubMed ID: 20381465
[TBL] [Abstract][Full Text] [Related]
33. Role of central 5-HT(2) receptors in fluoxetine-induced decreases in T lymphocyte activity.
Pellegrino TC; Bayer BM
Brain Behav Immun; 2002 Apr; 16(2):87-103. PubMed ID: 11908920
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors.
Barton CL; Hutson PH
Synapse; 1999 Jan; 31(1):13-9. PubMed ID: 10025679
[TBL] [Abstract][Full Text] [Related]
35. Pindolol potentiates the effect of fluoxetine on hippocampal seizures in rats.
Wada Y; Hirao N; Shiraishi J; Nakamura M; Koshino Y
Neurosci Lett; 1999 May; 267(1):61-4. PubMed ID: 10400249
[TBL] [Abstract][Full Text] [Related]
36. LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat.
Mitchell SN; Greenslade RG; Cooper J
Eur J Pharmacol; 2001 Nov; 432(1):19-27. PubMed ID: 11734183
[TBL] [Abstract][Full Text] [Related]
37. Chronic fluoxetine induces opposite changes in G protein coupling at pre and postsynaptic 5-HT1A receptors in rat brain.
Castro M; Diaz A; del Olmo E; Pazos A
Neuropharmacology; 2003 Jan; 44(1):93-101. PubMed ID: 12559126
[TBL] [Abstract][Full Text] [Related]
38. Differential cardiac sympatho-inhibitory responses produced by the agonists B-HT 933, quinpirole and immepip in normoglycaemic and diabetic pithed rats.
Rivera-Mancilla E; Altamirano-Espinoza AH; Manrique-Maldonado G; Villanueva-Castillo B; Villalón CM
Clin Exp Pharmacol Physiol; 2018 Aug; 45(8):767-778. PubMed ID: 29675928
[TBL] [Abstract][Full Text] [Related]
39. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.
Germonpré PR; Joos GF; Pauwels RA
Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563
[TBL] [Abstract][Full Text] [Related]
40. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.
Millan MJ; Newman-Tancredi A; Rivet JM; Brocco M; Lacroix P; Audinot V; Cistarelli L; Gobert A
J Pharmacol Exp Ther; 1997 Jul; 282(1):132-47. PubMed ID: 9223549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]